WALTHAM, Mass.– September 6, 2023 – Danforth Advisors, LLC, today announced the acquisition of Elite BioPharma Consulting, Inc., broadening the range of its newly formed Development Strategy and Operations (DS&O) practice and supporting life science companies in the advancement of preclinical and clinical programs without the burden of fixed costs. With the acquisition of Elite,....
Read MoreNews
Learn more about developments and insights from Avesi Partners.
Newsletter
Featured Story
Danforth Advisors Acquires Elite BioPharma Consulting
All News